Human C1-Esterase Inhibitor vs Pembrolizumab

## Human C1-Esterase Inhibitor vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Human C1-Esterase Inhibitor** and **Pembrolizumab**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Human C1-Esterase Inhibitor — N/A; Pembrolizumab — 26 days.

## Chemical Properties

**Type**: Human C1-Esterase Inhibitor — Protein; Pembrolizumab — Antibody.